
The U.S. Food and Drug Administration (FDA) on Thursday announced the recall of a thyroid medication after it was found that lots of the drug may be “subpotent.”

The U.S. Food and Drug Administration (FDA) will give priority status to an over-the-counter opium overdose antidote nasal spray submitted for review, the pharmaceutical company said Monday.

A drug manufacturer announced this week it is recalling lots of blood pressure medication Quinapril after a cancer-causing impurity was discovered, according to an announcement carried by the U.S. Food and Drug Administration (FDA).

The U.S. Food and Drug Administration has reported a shortage in the United States of the oral solution of amoxicillin, an antibiotic that’s widely used for bacterial infections, amid reports from authorities in several other countries of shortages of the same drug.

The U.S. Food and Drug Administration (FDA) on Sept. 28 proposed changes to what criteria certain food product should meet for it to be labeled “healthy.”

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s gene therapy for the treatment of a rare neurological disorder, the company said late on Friday.

PUNTA GORDA, Fla.—For 630 days a warehouse in Lakeland has sat vacant—waiting on a shipment of drugs from Canada that never came.

Lyons Magnus, a California-based food and beverage manufacturing company, voluntarily recalled dozens of nutritional and beverage products over potential microbial contamination—including from the organism cronobacter sakazakii.

The U.S. Food and Drug Administration (FDA) on Tuesday paused its marketing denial order on Juul e-cigarettes while it carries out a review into “scientific issues” unique to the company’s application.

The Food and Drugs Administration (FDA) banned all of JUUL Labs Inc’s products on June 23 from the market, delivering a blow to the popular e-cigarette company.

A Food and Drug Administration (FDA) advisory panel on June 15 voted to recommend the FDA give emergency authorization to the Moderna and Pfizer COVID-19 vaccines for children as young as 6 months of age.

Food and Drug Administration (FDA) Commissioner Robert Califf said the severe nationwide shortage of baby formula is expected to be eased within two months.